Aptahem AB (publ) (NGM:APTA)
1.080
-0.210 (-16.28%)
At close: Nov 6, 2025
Aptahem AB Revenue
Aptahem AB had revenue of 787.00K SEK in the quarter ending June 30, 2025, a decrease of -40.11%. This brings the company's revenue in the last twelve months to 2.80M, down -76.22% year-over-year. In the year 2024, Aptahem AB had annual revenue of 3.77M, down -63.95%.
Revenue (ttm)
2.80M
Revenue Growth
-76.22%
P/S Ratio
8.86
Revenue / Employee
560.99K
Employees
4
Market Cap
24.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.77M | -6.69M | -63.95% |
| Dec 31, 2023 | 10.46M | 7.02M | 203.47% |
| Dec 31, 2022 | 3.45M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |